XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.21.2

SEGMENT INFORMATION (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information | The segment information is summarized as follows:
Business Segment Assets |  | June 30, 2021 |  | December 31, 2020
Human Nutrition & Health |  | $ | 721,428 |  |  | $ | 717,232 |
Animal Nutrition & Health |  | 156,597 |  |  | 157,454 |
Specialty Products |  | 194,140 |  |  | 190,449 |
Other and Unallocated (1) |  | 101,441 |  |  | 100,708 |
Total |  | $ | 1,173,606 |  |  | $ | 1,165,843 |
Business Segment Net Sales |  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Human Nutrition & Health |  | $ | 111,471 |  |  | $ | 97,428 |  |  | $ | 215,987 |  |  | $ | 192,936 |
Animal Nutrition & Health |  | 54,481 |  |  | 46,344 |  |  | 105,629 |  |  | 94,985 |
Specialty Products |  | 34,022 |  |  | 28,194 |  |  | 62,030 |  |  | 56,190 |
Other and Unallocated (2) |  | 2,391 |  |  | 1,389 |  |  | 4,375 |  |  | 3,680 |
Total |  | $ | 202,365 |  |  | $ | 173,355 |  |  | $ | 388,021 |  |  | $ | 347,791 |
Business Segment Earnings Before Income Taxes |  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Human Nutrition & Health |  | $ | 19,021 |  |  | $ | 15,497 |  |  | $ | 38,711 |  |  | $ | 27,632 |
Animal Nutrition & Health |  | 3,561 |  |  | 6,430 |  |  | 8,617 |  |  | 14,474 |
Specialty Products |  | 9,729 |  |  | 8,008 |  |  | 16,918 |  |  | 15,994 |
Other and Unallocated (2) |  | (1,718) |  |  | (3,018) |  |  | (3,078) |  |  | (4,905) |
Interest and other expense |  | (574) |  |  | (944) |  |  | (1,166) |  |  | (2,732) |
Total |  | $ | 30,019 |  |  | $ | 25,973 |  |  | $ | 60,002 |  |  | $ | 50,463 |
Depreciation/Amortization |  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Human Nutrition & Health |  | $ | 7,441 |  |  | $ | 8,015 |  |  | $ | 15,014 |  |  | $ | 15,859 |
Animal Nutrition & Health |  | 1,816 |  |  | 1,793 |  |  | 3,580 |  |  | 3,548 |
Specialty Products |  | 2,085 |  |  | 2,372 |  |  | 4,354 |  |  | 4,764 |
Other and Unallocated (2) |  | 757 |  |  | 565 |  |  | 1,515 |  |  | 1,123 |
Total |  | $ | 12,099 |  |  | $ | 12,745 |  |  | $ | 24,463 |  |  | $ | 25,294 |
Capital Expenditures |  | Six Months Ended June 30,
|  | 2021 |  | 2020
Human Nutrition & Health |  | $ | 8,883 |  |  | $ | 8,884 |
Animal Nutrition & Health |  | 2,729 |  |  | 2,446 |
Specialty Products |  | 1,448 |  |  | 958 |
Other and Unallocated (2) |  | 66 |  |  | 87 |
Total |  | $ | 13,126 |  |  | $ | 12,375 |
(1) Other and Unallocated assets consist of certain cash, capitalized loan issuance costs, other assets, investments, and income taxes, which the Company does not allocate to its individual business segments. It also includes assets associated with a few minor businesses which individually do not meet the quantitative thresholds for separate presentation.
(2) Other and Unallocated consists of a few minor businesses which individually do not meet the quantitative thresholds for separate presentation and corporate expenses that have not been allocated to a segment. Unallocated corporate expenses consist of: (i) Transaction and integration costs, ERP implementation costs, and unallocated legal fees totaling $466 and $700 for the three and six months ended June 30, 2021, respectively, and $746 and $2,018 for the three and six months ended June 30, 2020, respectively, and (ii) Unallocated amortization expense of $674 and $1,349 for the three and six months ended June 30, 2021, respectively, and $475 and $947 for the three and six months ended June 30, 2020, respectively, related to an intangible asset in connection with a company-wide ERP system implementation and capitalized loan issuance costs that was included in interest expense in the Company's consolidated statement of earnings.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration